|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/498 | |
| A61P 17/00 | |||
| A61K 9/06 | |||
| A61K 9/00 |
| (11) | Number of the document | 2552448 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11709960.6 |
| Date of filing the European patent application | 2011-03-25 | |
| (97) | Date of publication of the European application | 2013-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/054597 |
| Date | 2011-03-25 |
| (87) | Number | WO 2011/117378 |
| Date | 2011-09-29 |
| (30) | Number | Date | Country code |
| 282753 P | 2010-03-26 | US |
| (72) |
GRAEBER, Michael, US
LOESCHE, Christian, FR
FREIDENREICH, Philip, US
LIU, Yin, US
LEONI, Matthew James, US
|
| (73) |
Galderma Research & Development,
2400 Route des Colles Les Templiers, 06410 Biot,
FR
|
| (54) | IMPROVED COMPOSITIONS COMPRISING BRIMONIDINE FOR SAFE AND EFFECTIVE TREATMENT OF TELANGIECTASIA |
| IMPROVED COMPOSITIONS COMPRISING BRIMONIDINE FOR SAFE AND EFFECTIVE TREATMENT OF TELANGIECTASIA |